endometrial carcinoma: A malignant tumor arising from the epithelium that lines the cavity of the uterine body. The vast majority of endometrial carcinomas are adenocarcinomas; squamous cell and adenosquamous carcinomas represent a minority of the cases. Endometrioid adenocarcinoma is the most frequently seen variant of endometrial adenocarcinoma. Uterine bleeding is an initial clinical sign. The prognosis depends on the stage of the tumor, the depth of myometrial wall invasion, and the degree of differentiation.
| Name | C3_CORPUS_UTERI |
|---|---|
| Long name | Malignant neoplasm of corpus uteri |
| Cause of Death registry | ICD-10: C54, ICD-9: 182, ICD-8: 1820 |
| Cancer reg: TOPOGRAPHY codes | C54 |
| Sex specific endpoint | 2 |
| Level in the ICD-hierarchy | 3 |
| First defined in version | DF4 |
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1053 | 1053 | - |
| Unadjusted prevalence (%) | 0.49 | 0.86 | - |
| Mean age at first event (years) | 63.50 | 63.50 | - |
| Case fatality at 5-years (%) | 6.84 | 6.84 | - |
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 1.0 | 1.0 | - |
| Recurrence at 6 months (%) | 1.33 | 1.33 | - |
before Malignant neoplasm of corpus uteri
after Malignant neoplasm of corpus uteri
Loading survival analyses plot…
Loading survival analyses table…